Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $4.69 -0.42%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ARRAY Technologies to Detail Balance-of-System Strategy and APA Long-Term Growth Opportunities at the APA Investor Technology Showcase Today
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
